TransEngen Inc. raised $2.5 million in its latest funding round.
The healthcare payment software developer’s equity-based raise commenced July 27 and included six investors, according to Securities & Exchange Commission documents.
The filing names as directors Randall Schmidt of Minneapolis, Minn.-based Lemhi Ventures Fund I LP; Athanasios Hasiotis and Roy Trice of Dallas, Texas-based Carlson Capital LP. According to TransEgen’s website, the three men sit on the company’s board. Lemhi Ventures is a previous investor in the Norwalk, Conn.-based company, which until last April was known as TriHealix.